What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.
Business Of Biotech · 67 minutes ·

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

As COVID-19 cases climb yet again,  the Business of Biotech catches up with Tonix Pharmaceuticals CEO Seth Lederman, M.D. for a conversation on his company's multi-pronged strategy to advance vaccine and therapeutic candidates to address the disease and its variants. In addition to sharing on his journey from academia to industry, Dr. Lederman discusses his company's approach to grabbing its share of the highly competitive, and highly lucrative, vaccine market.

Comments (0)

You Must Be Logged In To Comment

Similar podcasts

COVID-19 Vaccines: An Evolving Landscape

Life Sciences Connect

What's Next with Eric Wood

What's Next! with Tiffani Bova

What's Next In

What's Next God?

Remember What's Next

Building What's Next